About: High antileukemic efficacy of an intermediate intensity conditioning regimen for allogeneic stem cell transplantation in patients with high-risk acute myeloid leukemia in first complete remission

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: High antileukemic efficacy of an intermediate intensity conditioning regimen for allogeneic stem cell transplantation in patients with high-risk acute myeloid leukemia in first complete remission Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 07 January 2008

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) article scientifique publié en 2008 (fr) наукова стаття, опублікована в січні 2008 (uk) im Januar 2008 veröffentlichter wissenschaftlicher Artikel (de) artículu científicu espublizáu en xineru de 2008 (ast) scientific article published on 07 January 2008 (en)
publication date	wds:Q60326486-61BB4E3D-D32B-492B-91BC-C70ED9AE105B
publication date	2008-01-07 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q60326486-F2B23BAE-17E9-425A-9401-8E7578895FC2
language of work or name	English
exact match	wds:Q60326486-623262AD-9E1C-4E1D-9B23-CE96A926E0BD
exact match	https://scigraph.springernature.com/pub.10.1038/sj.bmt.1705965
cites work	wds:Q60326486-1DFA5CEF-48BA-4BDD-9E2B-C9D21FBC0205 wds:Q60326486-2C548604-31E3-4344-A38B-3DDCA3B1F505 wds:Q60326486-2D784CA8-CB1E-4512-9634-523301D8B2C4 wds:Q60326486-353466EC-874A-4EC1-B671-7C2CC3484542 wds:Q60326486-3A20F16F-D814-4E79-BDED-2CD4DC456A7E wds:Q60326486-3AF0C77C-E608-46E6-9082-A467800B40FA wds:Q60326486-3C45E2C3-EDE3-4398-B27B-86D851466F8C wds:Q60326486-3EA7EED3-995D-4EDD-868E-18601926272F wds:Q60326486-40104307-9BF8-4A25-AB80-4D518D782CCB wds:Q60326486-44CA8C7D-8B08-4A51-BD87-34BC608CA616 wds:Q60326486-647A7AE1-25EC-4A8F-A681-DF7DB8F163D0 wds:Q60326486-666017F8-BF3F-48BA-BD06-0A79EABDB98E wds:Q60326486-6B13B891-D25D-4BF8-9C87-4615AD264901 wds:Q60326486-84A4CC11-A3D2-4FF9-B9C9-6C6E94B7A000 wds:Q60326486-ACD7F762-D813-462B-8827-3F9FCEFBFC58 wds:Q60326486-B5D3EFEA-E598-4625-91AB-433FB14BF065 wds:Q60326486-B7DEFFD9-D276-4971-A286-4E8A08837FA0 wds:Q60326486-BF2C6326-8FD3-4F01-9F5A-C257C86A6B43 wds:Q60326486-BF636C64-4A9D-46B9-BD56-4D5CE7228712 wds:Q60326486-C15627E9-B35D-46F0-BEEC-8087474E29CD wds:Q60326486-C3A274EF-2C0B-436C-B302-49183DFEC72D wds:Q60326486-D18D8FCA-9405-45D9-BDA4-7B4A47F59E8A wds:Q60326486-E1CAF00C-DC7D-4C49-8328-615EE7599981 wds:Q60326486-E610C26B-99D7-4373-BC22-11B8503B7478 wds:Q60326486-F14B0058-4410-418A-8D2B-13E73126F73D wds:Q60326486-F2A5001A-60A5-4FC7-B513-A3736C10EBD1 wds:Q60326486-F4A685B3-137F-416E-BFAC-96C9AF6BC1D6 wds:Q60326486-FD148365-6BC4-4AD2-91E1-1F9C124B2408
cites work	Pretreatment cytogenetic abnormalities are predictive of induction success, cumulative incidence of relapse, and overall survival in adult patients with de novo acute myeloid leukemia: results from Cancer and Leukemia Group B (CALGB 8461) Early blast clearance by remission induction therapy is a major independent prognostic factor for both achievement of complete remission and long-term outcome in acute myeloid leukemia: data from the German AML Cooperative Group (AMLCG) 1992 Trial Karyotype is an independent prognostic parameter in therapy-related acute myeloid leukemia (t-AML): an analysis of 93 patients with t-AML in comparison to 1091 patients with de novo AML Revised recommendations of the International Working Group for Diagnosis, Standardization of Response Criteria, Treatment Outcomes, and Reporting Standards for Therapeutic Trials in Acute Myeloid Leukemia Allogeneic hematopoietic stem-cell transplantation in AML and MDS using myeloablative versus reduced-intensity conditioning: the role of dose intensity Acute myeloid leukemia Individual patient data-based meta-analysis of patients aged 16 to 60 years with core binding factor acute myeloid leukemia: a survey of the German Acute Myeloid Leukemia Intergroup Results of a HOVON/SAKK donor versus no-donor analysis of myeloablative HLA-identical sibling stem cell transplantation in first remission acute myeloid leukemia in young and middle-aged adults: benefits for whom? Long-term survival in refractory acute myeloid leukemia after sequential treatment with chemotherapy and reduced-intensity conditioning for allogeneic stem cell transplantation Comparative outcome of reduced intensity and myeloablative conditioning regimen in HLA identical sibling allogeneic haematopoietic stem cell transplantation for patients older than 50 years of age with acute myeloblastic leukaemia: a retrospective s Allogeneic stem-cell transplantation using a reduced-intensity conditioning regimen has the capacity to produce durable remissions and long-term disease-free survival in patients with high-risk acute myeloid leukemia and myelodysplasia Treatment for acute myelogenous leukemia by low-dose, total-body, irradiation-based conditioning and hematopoietic cell transplantation from related and unrelated donors Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT Evidence for a graft-versus-leukemia effect after allogeneic peripheral blood stem cell transplantation with reduced-intensity conditioning in acute myelogenous leukemia and myelodysplastic syndromes. Myeloablative vs nonmyeloablative allogeneic transplantation for patients with myelodysplastic syndrome or acute myelogenous leukemia with multilineage dysplasia: a retrospective analysis Conditioning with 8-Gy total body irradiation and fludarabine for allogeneic hematopoietic stem cell transplantation in acute myeloid leukemia A simple, robust, validated and highly predictive index for the determination of risk-directed therapy in acute myeloid leukaemia derived from the MRC AML 10 trial Once-daily intravenous busulfan and fludarabine: clinical and pharmacokinetic results of a myeloablative, reduced-toxicity conditioning regimen for allogeneic stem cell transplantation in AML and MDS. Sequential regimen of chemotherapy, reduced-intensity conditioning for allogeneic stem-cell transplantation, and prophylactic donor lymphocyte transfusion in high-risk acute myeloid leukemia and myelodysplastic syndrome Hematopoietic stem-cell transplantation for treatment-related leukemia or myelodysplasia Fludarabine, melphalan, and alemtuzumab conditioning in adults with standard-risk advanced acute myeloid leukemia and myelodysplastic syndrome Reduced-intensity conditioning for unrelated donor hematopoietic stem cell transplantation as treatment for myeloid malignancies in patients older than 55 years Nonablative versus reduced-intensity conditioning regimens in the treatment of acute myeloid leukemia and high-risk myelodysplastic syndrome: dose is relevant for long-term disease control after allogeneic hematopoietic stem cell transplantation Reduced intensity conditioning prior to allogeneic stem cell transplantation for patients with acute myeloblastic leukemia as a first-line treatment Allogeneic Stem-Cell Transplantation From Related and Unrelated Donors in Older Patients With Myeloid Leukemia Durable remissions of myelodysplastic syndrome and acute myeloid leukemia after reduced-intensity allografting Evaluation and application of the AmpF/STR profiler plus PCR amplification kit in a Bavarian population sample Who should be transplanted for AML?
author name string	wds:Q60326486-128F85A3-3C19-4C1B-9CA6-C55F36881E96 wds:Q60326486-1CED5925-042C-4982-A4A1-C5D0B9E5F108 wds:Q60326486-451369AE-685B-454D-B5AD-9659BC445FFF wds:Q60326486-4D601B3B-02E9-49EE-9390-F5862EC4BD7A wds:Q60326486-5520DE14-70F1-45B6-8E02-1D58F1A22929 wds:Q60326486-6DCFF9A1-9E8F-490B-B0A2-3D6608B25AA9 wds:Q60326486-851E572B-B9F2-444B-9501-A6E704A9B63E wds:Q60326486-91E7D43D-54EA-4CB1-B9BB-D22325C760C1 wds:Q60326486-9B5B6FB5-8A7D-43C6-93BD-6B4C9C9C91D1 wds:Q60326486-DE77FC8E-7E58-4A2D-A9A7-D46D658D1989
author name string	C Schmid W Hiddemann A Gerbitz M Hentrich H-J Kolb M Schleuning G Ledderose J Tischer D Oruzio G E Markl
rdfs:label	High antileukemic efficacy of an intermediate intensity conditioning regimen for allogeneic stem cell transplantation in patients with high-risk acute myeloid leukemia in first complete remission (en) High antileukemic efficacy of an intermediate intensity conditioning regimen for allogeneic stem cell transplantation in patients with high-risk acute myeloid leukemia in first complete remission (nl)
skos:prefLabel	High antileukemic efficacy of an intermediate intensity conditioning regimen for allogeneic stem cell transplantation in patients with high-risk acute myeloid leukemia in first complete remission (en) High antileukemic efficacy of an intermediate intensity conditioning regimen for allogeneic stem cell transplantation in patients with high-risk acute myeloid leukemia in first complete remission (nl)
name	High antileukemic efficacy of an intermediate intensity conditioning regimen for allogeneic stem cell transplantation in patients with high-risk acute myeloid leukemia in first complete remission (en) High antileukemic efficacy of an intermediate intensity conditioning regimen for allogeneic stem cell transplantation in patients with high-risk acute myeloid leukemia in first complete remission (nl)
title	wds:Q60326486-DE278265-EED5-4122-B055-C96D3FD0D40F
title	High antileukemic efficacy of an intermediate intensity conditioning regimen for allogeneic stem cell transplantation in patients with high-risk acute myeloid leukemia in first complete remission (en)
page(s)	wds:Q60326486-DB903EFD-D4CF-4030-8F1C-B4938B684634
page(s)	721-727
instance of	wds:Q60326486-9F5ABB78-8D2C-4947-BDC6-2879835F934A

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 172 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software